比利时Concentra生物科学公司以每股1.047美元的价格购买美国生物技术iTeos治疗技术。 Belgian firm Concentra Biosciences acquires US biotech iTeos Therapeutics for $10.047 per share.

美国生物技术公司iTeos治疗技术将由比利时Concentra Biosciences公司收购,每分现金为1.047美元,外加对iTeos股东增加价值的或有价值权利。 US biotech company iTeos Therapeutics is set to be acquired by Belgian firm Concentra Biosciences for $10.047 per share in cash, plus a contingent value right that could add more value for iTeos shareholders. 该交易需要在2025年8月1日之前提交招标报价,预计在某些条件下将于2025年第三季度完成. The deal, which requires a tender offer by August 1, 2025, is expected to close by the third quarter of 2025, pending certain conditions. iTeos董事会一致批准该收购,认为这是对其股东有利的。 The iTeos board unanimously approved the acquisition, seeing it as beneficial for its stockholders.